MICROSAIC SYSTEMS Stock London S.E.

Equities

MSYS

GB00B547ZY09

Office Equipment

Market Closed - London S.E. 11:35:17 2024-04-18 am EDT 5-day change 1st Jan Change
1.05 GBX 0.00% Intraday chart for MICROSAIC SYSTEMS 0.00% 0.00%
Sales 2021 907K 1.13M Sales 2022 1.57M 1.95M Capitalization 2.04M 2.53M
Net income 2021 -3M -3.73M Net income 2022 -2M -2.49M EV / Sales 2021 6.37 x
Net cash position 2021 3.34M 4.15M Net cash position 2022 1.19M 1.47M EV / Sales 2022 0.54 x
P/E ratio 2021
-2.65 x
P/E ratio 2022
-0.88 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 82.83%
More Fundamentals * Assessed data
Dynamic Chart
Current month-14.29%
1 month-19.23%
3 months-25.00%
More quotes
1 week
0.98
Extreme 0.98
1.10
1 month
0.98
Extreme 0.98
1.30
3 years
0.98
Extreme 0.98
190.50
5 years
0.98
Extreme 0.98
1 324.19
10 years
0.98
Extreme 0.98
31 875.00
More quotes
Date Price Change Volume
24-04-18 1.05 0.00% 100 156
24-04-17 1.05 0.00% 152,122
24-04-16 1.05 0.00% 295,000
24-04-15 1.05 0.00% 264,804
24-04-12 1.05 0.00% 41,281

Delayed Quote London S.E., April 18, 2024 at 11:35 am EDT

More quotes
Microsaic Systems plc is a United Kingdom-based company that develops real-time, point-of-need mass spectrometers, and provides turnkey solutions to improve the efficiency of chemical and biological workflows. The Company’s core products, such as the compact MiD series of mass detectors, are designed to integrate with a range of third-party original equipment manufacturer (OEM) equipment or used as a standalone system. Its products include the MiD Platform, MiDas Automated Sampling, MiD ProteinID and SPE-LC-MS. Its MiD products and integrated software provide insights into biological or chemical samples and reactions. The Company’s MiDas compact sampling interface allows automated sampling, dilution, and injection for direct mass spectrometer analysis. Its MiD ProteinID allows verify target protein through the whole bioprocess, from cell train to bioreactor to capture to fill. Its SPE-LC-MS is designed to extract and analyses low-concentration samples at the point-of-need.
More about the company